Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Legend Biotech Corp stock
Learn how to easily invest in Legend Biotech Corp stock.
Legend Biotech Corp is a biotechnology business based in the US. Legend Biotech Corp shares (LEGN) are listed on the NASDAQ and all prices are listed in US Dollars. Legend Biotech Corp employs 1,071 staff and has a trailing 12-month revenue of around $118.6 million.
How to buy shares in Legend Biotech Corp
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LEGN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Legend Biotech Corp stock price (NASDAQ: LEGN)Use our graph to track the performance of LEGN stocks over time.
Legend Biotech Corp shares at a glance
|Latest market close||$40.80|
|52-week range||$30.76 - $58.00|
|50-day moving average||$45.81|
|200-day moving average||$43.39|
|Wall St. target price||$66.86|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.37|
Buy Legend Biotech Corp shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Legend Biotech Corp stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Legend Biotech Corp price performance over time
|1 week (2022-09-23)||5.15%|
|1 month (2022-09-01)||-12.76%|
|3 months (2022-07-01)||-26.93%|
|6 months (2022-04-01)||4.35%|
|1 year (2021-10-01)||-18.74%|
|2 years (2020-10-01)||31.57%|
|3 years (2019-09-27)||N/A|
|5 years (2017-09-27)||N/A|
Legend Biotech Corp financials
|Revenue TTM||$118.6 million|
|Gross profit TTM||$91.6 million|
|Return on assets TTM||-27.65%|
|Return on equity TTM||-107.41%|
|Market capitalisation||$6.5 billion|
TTM: trailing 12 months
Legend Biotech Corp share dividends
We're not expecting Legend Biotech Corp to pay a dividend over the next 12 months.
Legend Biotech Corp share price volatility
Over the last 12 months, Legend Biotech Corp's shares have ranged in value from as little as $30.755 up to $58. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Legend Biotech Corp's is -0.6627. This would suggest that Legend Biotech Corp's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Legend Biotech Corp has bucked the trend.
Legend Biotech Corp overview
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candidates targeting CD20/CD22/CD19 for the treatment of non-hodgkins lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukemia. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel.
Legend Biotech Corp in the news
CARVYKTI™ (ciltacabtagene autoleucel) Receives Approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Legend Biotech to Host 2022 R&D Day on Monday, October 3, 2022
Frequently asked questionsWhat percentage of Legend Biotech Corp is owned by insiders or institutions?
Currently 1.349% of Legend Biotech Corp shares are held by insiders and 32.147% by institutions. How many people work for Legend Biotech Corp?
Latest data suggests 1,071 work at Legend Biotech Corp. When does the fiscal year end for Legend Biotech Corp?
Legend Biotech Corp's fiscal year ends in December. Where is Legend Biotech Corp based?
Legend Biotech Corp's address is: 2101 Cottontail Lane, Somerset, NJ, United States, 08873 What is Legend Biotech Corp's ISIN number?
Legend Biotech Corp's international securities identification number is: US52490G1022
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert